Marco Maruzzo - Concepedia

Author

Marco Maruzzo

Also Known As

Daniele Marinelli, Francesco Cattaneo, M Maruzzo, M. MARUZZO, M. Maruzzo, M.M. Maruzzo, MARCO MARUZZO, MARUZZO, MARCO, Marco MARUZZO, Marco Maruzzo

306

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Istituto Oncologico Veneto Istituti di Ricovero e Cura a Carattere Scientifico Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori University of Parma Fondazione IRCCS Istituto Nazionale dei Tumori

About

Marco Maruzzo is an author at Istituto Oncologico Veneto specializing in oncology, medicine, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	24	940
2	Health Sciences	6	6	145
3	Geriatrics	2	2	35
4	Immunology	1	1	53
5	Nephrology	1	1	16

Marco Maruzzo

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Treatment of Estrogen Receptor-Positive Breast Cancer Franco Lumachi, Antonella Brunello, Marco Maruzzo, Current Medicinal Chemistry Breast OncologyMedicinePharmacologyEstrogen ReceptorGynecology	2013	291
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib Cristian Lolli, Umberto Basso, Lisa Derosa, Oncotarget	2016	150
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma Toni K. Choueiri, Thomas Powles, Laurence Albigès, New England Journal of Medicine	2023	142
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study) Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Therapeutic Advances in Medical Oncology	2021	86
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience Marco Maruzzo, Juan Martín-Liberal, Christina Messiou, Clinical Sarcoma Research	2015	84
A retrospective study of patients with malignant PEComa receiving treatment with sirolimus or temsirolimus: the Royal Marsden Hospital experience. Charlotte Benson, Joanna Vitfell-Rasmussen, Marco Maruzzo, PubMed	2014	81
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma Veronica Mollica, Matteo Santoni, Marc Matrana, Targeted Oncology UrologyOncologyPatients TreatedGenitourinary CancerPlus Ipilimumab	2021	75
Nivolumab + cabozantinib (NIVO+CABO) versus sunitinib (SUN) for advanced renal cell carcinoma (aRCC): Outcomes by sarcomatoid histology and updated trial results with extended follow-up of CheckMate 9ER. Robert J. Motzer, Toni K. Choueiri, Thomas Powles, Journal of Clinical Oncology Cancer ManagementPathologySarcomatoid HistologyPharmacotherapyTumor Biology	2021	70
Glycosaminoglycan Profiling in Patients’ Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma Francesco Gatto, Nicola Volpi, Helén Nilsson, Cell Reports	2016	57
First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study Sebastiano Buti, Melissa Bersanelli, Francesca Maines, Clinical Genitourinary Cancer UrologyGenitourinary CancerKidney ResearchMedicineSurgical Pathology	2016	54

Page 1